Biogen (BIIB) Earnings Date, Estimates & Call Transcripts $131.95 +3.95 (+3.09%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$132.24 +0.29 (+0.22%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Biogen Earnings Summary Biogen released Q2 2025 earnings on July 31, 2025, reporting an EPS of $5.47, which topped the consensus estimate of $3.93 by $1.54. Quarterly revenue rose 7.3% year-over-year to $2.65 billion, above analysts' expectations of $2.32 billion. With a trailing EPS of $10.13 and a P/E Ratio of 12.61, Biogen's earnings are expected to grow 4.30% next year, from $15.83 to $16.51 per share. Latest Q2 Earnings DateJul. 31EstimatedConsensus EPS (Jul. 31) $3.93 Actual EPS (Jul. 31) $5.47 Beat By $1.54 Actual Revenue (Jul. 31) $2.65BQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K) Slide DeckSEC FilingSlide DeckFull Screen Slide DeckPowered by Get Biogen Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biogen and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBIIB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIIB Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Biogen Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS GuidanceQ1 20254$2.70$3.87$3.48Q2 20254$3.83$4.15$4.04Q3 20254$3.81$4.14$3.96Q4 20254$3.58$4.19$3.89 FY 2025 16 $13.92 $16.35 $15.36 Q1 20263$3.42$4.60$4.01Q2 20263$4.08$4.60$4.33Q3 20263$3.35$3.93$3.67Q4 20263$3.38$3.88$3.65 FY 2026 12 $14.23 $17.01 $15.66 Q1 20271$4.37$4.37$4.37Q2 20271$4.95$4.95$4.95 Biogen Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails7/31/2025Q2 2025$3.93$5.47+$1.54$4.33$2.32B$2.65B5/1/2025Q1 2025$3.26$3.02 -$0.24$1.64$2.25B$2.43B2/12/2025Q4 2024$3.43$3.44+$0.01$1.83$2.42B-10/30/2024Q3 2024$3.77$4.08+$0.31$5.50$2.43B$2.47B8/1/2024Q2 2024$4.00$5.28+$1.28$6.56$2.39B$2.47B4/24/2024Q1 2024$3.45$3.67+$0.22$4.64$2.31B$2.29B2/13/2024Q4 2023$3.18$2.95 -$0.23$4.19$2.47B$2.39B11/8/2023Q3 2023$3.99$4.36+$0.37$9.19$2.40B$2.53B Biogen Earnings - Frequently Asked Questions When did Biogen announce their last quarterly earnings? Biogen (NASDAQ:BIIB) last announced its quarterly earning data on Thursday, July 31, 2025. Learn more on BIIB's earnings history. What guidance has Biogen issued on next quarter's earnings? Biogen issued an update on its FY 2025 earnings guidance on Thursday, July, 31st. The company provided earnings per share (EPS) guidance of 15.500-16.000 for the period, compared to the consensus earnings per share estimate of 14.980. The company issued revenue guidance of -. Did Biogen beat their earnings estimates last quarter? In the previous quarter, Biogen (NASDAQ:BIIB) reported $5.47 earnings per share (EPS) to beat the analysts' consensus estimate of $3.93 by $1.54. Learn more on analysts' earnings estimate vs. BIIB's actual earnings. How can I listen to Biogen's earnings conference call? The conference call for Biogen's latest earnings report can be listened to online. Listen to Conference Call How can I read Biogen's conference call transcript? The conference call transcript for Biogen's latest earnings report can be read online. Read Transcript How can I view Biogen's earnings report? Biogen's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Biogen generate each year? Biogen (NASDAQ:BIIB) has a recorded annual revenue of $9.68 billion. How much profit does Biogen generate each year? Biogen (NASDAQ:BIIB) has a recorded net income of $1.63 billion. BIIB has generated $10.13 earnings per share over the last four quarters. What is Biogen's price-to-earnings ratio? Biogen (NASDAQ:BIIB) has a trailing price-to-earnings ratio of 12.61 and a forward price-to-earnings ratio of 8.34. The price/earnings-to-growth ratio is 1.85. What is Biogen's EPS forecast for next year? Biogen's earnings are expected to grow from $15.83 per share to $16.51 per share in the next year, which is a 4.30% increase. More Earnings Resources from MarketBeat Related Companies Amgen Earnings Gilead Sciences Earnings Ionis Pharmaceuticals Earnings Moderna Earnings Prothena Earnings Sage Therapeutics Earnings Cassava Sciences Earnings Vertex Pharmaceuticals Earnings Bristol Myers Squibb Earnings Eli Lilly and Company Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Microsoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead?Amazon's Pre-Earnings Setup Is Almost Too Clean—Red Flag? This page (NASDAQ:BIIB) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
